Use of HLA-class I tetramers to rapidly define novel HIV-1 CD8+ T-cell epitopes. HLA-B*5703 tetramers were loaded with the indicated optimal peptides and stained against HLA-matched ex vivo donor PBMCs. (A) HLA-B*5702 tetramer loaded with QF10 RT (QATWIPEWEF) (subject, N099). (B) LF11 p17 (LVWASRELERF) (subject, R014), FF9 RT (FSVPLDEGF) (subject, N087), IAW9 RT (IAMESIVIW) (subject, N102), QF10 RT (QATWIPEWEF) (subject, R014), KF9 Nef (KTAVQMAVF) (subject, N102), HW9 Nef (HTQGFFPDW) (subject, R046, B*5701), QY10 Rev (QAVRIIKILY) (subject, R059), and LW9 Vif (LGHGVSIEW) (subject, N102). (C) HLA-B*5801 tetramers loaded with DW10 p24 (DTINEEAAEW) (subject, N067), QW9 p24 (QATQDVKNW) (subject, N067), IAW9 RT (IAMESIVIW) (subject, R007), HW9 Nef (HTQGFFPDW) (subject, N087), and KW11 Env (KAYEKEVHNVW) (subject, R076). The numbers in the gates are the percentages of tetramer-specific cells gated on live cells/CD3+ cells/lymphocytes shown as CD8 versus tetramer (B and C) or gated on CD8+ cells for PE and APC tetramer gating (A).